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CASE REPORT

Urticarial Rash in a Patient with Alpha-Gal Syndrome Caused
by Subcutaneous Heparin at Prophylactic Dosing: A Case
Report
Russell G. Behmer, MD,1 Randolph S. Thomas, MD,2 Hani T. Jarawan, MD, FACP2
1
2

Department of Internal Medicine, Maine Medical Center, Portland, ME
Department of Internal Medicine, Maine Medical Partners, Portland, ME

Introduction:

We report a patient with a history of red meat allergy, or alpha-gal syndrome, who had an urticarial
rash after exposure to unfractionated heparin at a dose typically used for prophylaxis of deep venous
thrombosis. Although anaphylactic reactions have been reported with systemic intravenous heparin, we
believe this case is the first report of an immunoglobulin E–mediated reaction to subcutaneous heparin
at prophylactic dosing.

Clinical Findings: An 85-year-old male had a 3-year history of red meat allergy and was intolerant of pork and beef. He
developed an immunoglobulin E–mediated allergic reaction to subcutaneous heparin at a dose of 5000
units twice daily.
Clinical Course:

The patient presented to the emergency department after a fall. He had back pain and was diagnosed
with a compression fracture. He was admitted to the hospital because he was unable to safely ambulate.
He was treated with subcutaneous unfractionated heparin to prevent deep venous thrombosis as part
of routine care. Twenty-four hours after exposure to heparin, he developed an urticarial rash. The rash
resolved promptly after discontinuing heparin and excluding other potential allergic triggers.

Conclusions:

In patients with alpha-gal syndrome, unfractionated heparin via a subcutaneous route at prophylactic
dosing can precipitate immunoglobulin E–mediated systemic reactions and should be avoided.

Keywords:

red meat allergy, heparin, food hypersensitivity, urticaria, alpha-gal syndrome

A

n 85-year-old male was admitted to the
hospital for a vertebral compression fracture.
His past medical history included coronary
artery disease and atrial fibrillation treated with
rivaroxaban. Three years prior, he developed hives,
nausea, vomiting, and diarrhea after eating beef
and pork. At that time, he reported occupational
exposure to ticks as a cattle farmer and no
recent travel. A lone star tick bite was presumed
from occupational exposure. At that time, he had
serologic evidence of allergy to galactose alpha1,3-galactose (alpha-gal), with an alpha-gal IgE
titer of 85.8 kU/L, and was diagnosed with alphagal syndrome.
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At admission, rivaroxaban was discontinued in
favor of aspirin and clopidogrel. On hospital day
4, he was given subcutaneous heparin at 5000
units twice daily for deep vein thrombosis (DVT)
prophylaxis. On hospital day 5, he developed hives
and was given cetirizine. On hospital day 6, his
rash worsened. Dermatology confirmed urticaria
without angioedema. The most likely etiology was
a medication allergy, likely due to heparin, aspirin,
or clopidogrel. The patient’s wife reported that the
rash appeared similar to when he consumed meat.
Staff had been attentive to his dietary intake and
reported no exposure to dietary pork or beef. Aspirin
and clopidogrel were continued, and heparin was
discontinued on hospital day 7. The patient received
a total of 7 doses of 5000 units subcutaneous
heparin. Figure 1 shows the appearance of the
rash on hospital day 9. The rash was improving on
hospital day 10 and had resolved by hospital day
13 (Figure 2).
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Figure 1. Urticarial Rash Developed in the
Patient on Hospital Day 9, After Exposure to
Subcutaneous Heparin

DISCUSSION
Alpha-gal syndrome is caused by immunoglobulin E
(IgE) antibodies to galactose alpha-1,3-galactose,
a surface mono-oligosaccharide found in nonprimate mammals.1 Alpha-gal syndrome often
clinically manifests as delayed anaphylaxis 3 to 6
hours after red meat ingestion and develops after
tick bite, usually by the lone star tick (Amblyomma
americanum) in the United States.2 These tick bites
are theorized to cause basophil, eosinophil, and
type-2 cytokine-producing T-cell infiltration, which
results in production of alpha-gal IgE antibody via
signaling pathways involving myeloid differentiation
factor 88.3,4
Although meat intolerance is the most consistent
manifestation, alpha-gal is also present at varying
small amounts in medications, which may cause
IgE-mediated reactions in patients who are
allergic to alpha-gal after exposure to one of these
medications. In fact, alpha-gal allergy was initially
discovered after systemic reactions to cetuximab,
which contains an alpha-gal component, proving
alpha-gal reactogenicity in the bloodstream as well
as the gastrointestinal tract.5 Heparin is derived
from bovine lung tissue and porcine intestine tissue,
and it may contain variable amounts of alpha-gal
depending on the lot number and manufacturer.1
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Figure 2. Urticarial Rash Improved in the Patient
on Hospital Day 13, After Stopping Heparin
Administration
Reports have described anaphylactic reactions to
systemic heparin in patients with alpha-gal allergy.
These reactions seem to directly correlate with
alpha-gal allergy, including significantly higher
alpha-gal IgE titers in patients with reactions
during cardiovascular surgery.1 However, previous
reports describe intravenous administration and
higher doses of heparin used for cardiopulmonary
bypass1, 6-8 or a left-ventricular assist device.9 Our
patient was exposed to a lower dose of heparin via
a subcutaneous route. In our literature review, we
did not find any reported cases of allergic reaction
to subcutaneous heparin in a patient with alphagal syndrome. Some studies reported tolerance of
subcutaneous dosing in patients who reacted to
parenteral doses during cardiac surgery.1,6
In addition to the lower dose and novel route of
administration, our patient resided in Northern
New England. Alpha-gal syndrome was initially
recognized around 2006. At this time, the incidence
of anaphylactic reactions following infusion of
the alpha-gal-containing medication cetuximab
increased in patients with cancer living in the
Southeastern United States. In 2006, the range of
the lone star tick was limited to the Southeastern
United States, leading to a causal link between the
lone star tick bite and alpha-gal sensitization.5 In
the past 15 years, however, the range of the lone
star tick has expanded and now includes most
2
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of Maine.13 Because this range has only recently
expanded to Northern New England, medical
providers in this area may be less aware of alphagal syndrome.
In the context of a cardiac emergency,
desensitization, pre-medication, or alternative
medications (bivalirudin, cangrelor) may be
considered and have been tested successfully.7, 8-11
However, considering the low risk of DVT and the
clear risk of anaphylactic reaction or severe nonanaphylactic reaction, as in our patient, we suggest
avoiding all heparin products in patients with alphagal syndrome for DVT prophylactic dosing. Nonheparinoid products, such as fondaparinux, should
be equally effective and carry no risk of allergic
reactions to alpha-gal. This advice may be prudent
for other medications thought to contain alpha-gal
that have reasonable alternatives, including opioids,
acetaminophen, pregabalin, and haloperidol.12
Ultimately, we hope to spark further research into
the reactivity and safety of subcutaneous heparin
in patients with alpha-gal syndrome.
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